EHD2 Antibodies

Santa Cruz Biotechnology delivers a wide array of EHD2 monoclonal antibodies for various research applications. Validated applications include western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EHD2, or EH domain-containing protein 2, plays a critical role in endocytosis and membrane trafficking, influencing cellular processes such as receptor recycling and signal transduction. EHD2 function is essential for maintaining cellular homeostasis and has implications in various diseases, including cancer and neurodegenerative disorders. Understanding EHD2's role in cellular processes can provide insights into potential therapeutic targets. Researchers worldwide rely on EHD2 monoclonal antibodies to advance their studies in membrane trafficking and endocytosis. The high specificity of EHD2 monoclonal antibodies enables precise detection and analysis of protein expression patterns and interactions. Santa Cruz Biotechnology monoclonal antibodies for EHD2 continue to support breakthrough discoveries in cell biology research and disease understanding.